ResearchReply to Borrás-Blasco: How Adherence Shapes Persistence in IPF Treatment: A Call for Real-World Insight
ResearchPatient preferences for food allergy treatments in the United States: a discrete choice experiment
ResearchHealth care resource utilization of patients with asthma and food allergy initiating omalizumab
ResearchPersistence of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Pulmonary Fibrosis Foundation Patient Registry Study
ResearchHealth care resource use and costs in patients with food allergies: a United States insurance claims database analysis
ResearchThe Impact of Autoantibodies on Outcomes in Patients with Idiopathic Pulmonary Fibrosis: Post-Hoc Analyses of the Phase III ASCEND Trial
ResearchPursuing Clinical Predictors and Biomarkers for Progression in ILD: Analysis of the Pulmonary Fibrosis Foundation (PFF) Registry
ResearchThe mental health burden of food allergies: Insights from patients and their caregivers from the Food Allergy Research & Education (FARE) Patient Registry
ResearchThe clinical burden of food allergies: Insights from the Food Allergy Research & Education (FARE) Patient Registry
ResearchUse of Race-Specific Equations in Pulmonary Function Tests Impedes Potential Eligibility for Care and Treatment of Pulmonary Fibrosis
ResearchAntitussive Use in Patients with Inadequately Controlled Moderate-to-Severe Asthma: A Post Hoc Analysis of the Omalizumab EXTRA Trial
ResearchPatients with allergic asthma have lower risk of severe COVID-19 outcomes than patients with nonallergic asthma